The Effect of Metformin on Reducing Lupus Flares

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This is a multicenter, randomised, double-blind placebo controlled trial on the efficacy and safety of add-on metformin to conventional immunosuppressants in systemic lupus erythematosus (SLE). The purpose of this study is to evaluate: 1) the effect of metformin on reducing disease flares; 2) the influence of metformin on corticosteroid sparing effect; 3) the influence of metformin on body mass index (BMI); 4) the safety of metformin.
Epistemonikos ID: 457935d53fdeb17003188401435066aff20ef210
First added on: May 12, 2024